Fundraising Fox

Osage University Partners2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

Interius BioTherapeuticsMay 2021 · $76M

BiotechPhiladelphia, US

Philip R. Johnson, M.D.(Executive Officer, Director)inDora Mitchell(Executive Officer)Lori Forrest(Executive Officer)Leon Moulder, Jr.(Director)Benjamin Lund(Director)

BoardTomas Kiselak(Director)

Co-investorsOUP (Osage University Partners)Pfizer Venture InvestmentsAgent CapitalBain Capital Life SciencesLongwood FundPfizer Ventures+2 more

Vanqua BioSep 2021

BiotechChicago, US

Rand Sutherland(Director)James Sullivan(Executive Officer, Director)in

BoardJonathan Silverstein(Director)inBernard Davitian(Director)Uya Chuluunbaatar(Director)Mona Ashiya(Director)in

Co-investorsPontifax Venture CapitalAvoro VenturesCasdin CapitalOrbiMed

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.